Journals / Bakırköy Tıp Dergisi / 2013 / Cilt: 9 - Sayı: 1

Venous tromboembolism prophylaxis practices at surgery clinics

Cerrahi kliniklerinde venöz tromboemboli profilaksisi uygulamaları

Pages
8–11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

DVT and VTE can be prevented by determining the risk levels of patients using scoring systems and administrating appropriate prophylaxis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Venous tromboembolism is an important factor of morbidity and mortality for hospitalized patients.
📊
Key Findings & Data:In this study, our aim was to determine the level of risk for DVT and PE who were operated in our clinic and to indicate the prevention by appropriate prophylaxis.
💡
Conclusion & Impact:DVT and VTE can be prevented by determining the risk levels of patients using scoring systems and administrating appropriate prophylaxis.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Venous tromboembolism is an important factor of morbidity and mortality for hospitalized patients. Recently, despite the progression on diagnosis and treatment, diciplinary approaches to prophylaxis, consisting of a consensus cannot be applied. In this study, our aim was to determine the level of risk for DVT and PE who were operated in our clinic and to indicate the prevention by appropriate prophylaxis. Material and Methods: 432 patients, who were admitted to our clinic and underwent oncologic or laparoscopic operations between Jan. 2007 and Jan. 2010 were included in this study. The age, sex, duration of admission, risk levels for VTE, risk factors and results of prophylaxis were determined. Results: 214 patients were female and 218 were male. Mean age was 48 (24-80). The mean lenght of stay was 6 (2-25) days. Very-highrisk group included 19 patients (4,4%), whereas high-risk group included 49 (11,3%), medium-risk group included 71(16,4%) and low-risk group included 293 (67,9%) patients. Prophylaxis included early mobilization for low-risk group, 2 doses of LMWH in 24 hours for mediumrisk group, LMWH for 7-10 days for high-risk group and LMWH, antiembolic socks, early mobilization and IPC (intermittant pneumotic compression) for very-high risk group. 2 patients had DVT and 1 had PE under appropriate prophylaxis. No mortality occured. Conclusion: Pulmonary embolism is a preventable cause of death that among hospitalized patients. There is no consensus on prophylaxis in surgical clinics. DVT and VTE can be prevented by determining the risk levels of patients using scoring systems and administrating appropriate prophylaxis.

Özet

Amaç: Venöz tromboembolizm hastanede yatan hastalar için önemli bir morbidite ve mortalite nedenidir. Son yıllarda tanı ve tedavi alanındaki gelişmelere rağmen özellikle profilaksi konusunda konsensus oluşmuş disipliner yaklaşımlar uygulanamamaktadır. Bu çalışmadaki amacımız kliniğimizde ameliyat edilen hastalarda derin ven trombozu (DVT) ve pulmoner emboli (PE) risk düzeyini belirlemek ve bunun uygun yapılan venöz tromboemboli (VTE) profilaksisi ile önlenebildiğini göstermektir. Gereç ve Yöntem: Ocak 2007 - Ocak 2010 tarihleri arasında kliniğimizde yatış yapılıp laparoskopik cerrahi ve onkolojik cerrahi yapılan 432 hasta çalışmaya dahil edildi. Hastaların yaş, cinsiyet, hastanede kalış süreleri, VTE risk düzeyleri, risk faktörleri ve profilaksi sonuçları incelendi. Bulgular: Hastaların 214 ü kadın 218 ı erkek idi. Ortalama yaş 48 (24-80) olarak belirlendi. Ortalama hastanede kalış süresi 6 (2-25) gün idi. 432 hastanın 19’u (% 4,4) çok-yüksek-riskli, 49’u (% 11,3) yüksek-riskli, 71’i (% 16,4) orta-riskli, 293’ü (% 67,9) düşük-riskli gruptan idi. Düşük-riskli gruba erken mobilizasyon, orta-riskli gruba DMAH 24 saat ara ile 2 doz, yüksek-riskli gruba DMAH 7-10 gün, çok-yüksek-riskli gruba ise DMAH, antiembolik çorap, erken mobilizasyon ve IPC (kompresyon çorabı) uygulandı. Uygun profilaksi sonucu 2 hastada DVT ve 1 hastada PE görüldü. Hiçbir hastada mortalite görülmedi. Sonuç: Pulmoner emboli hastanede yatan hastalar arasında önlenebilir bir ölüm nedenidir. Cerrahi kliniklerinde profilaksi konusunda oluşmuş bir konsensus yoktur. Hastaların skorlama sistemleri ile risk düzeyleri belirlenip uygun profilaksi yapılarak DVT ve VTE önlenebilmektedir.

🔖

Cite This Article

KOÇ, B., KARATEPE, O., GELDİGİTTİ, T., TUTAL, F., KARAHAN, S. R. (2013). Venous tromboembolism prophylaxis practices at surgery clinics. Bakırköy Tıp Dergisi, Cilt: 9 - Sayı: 1, 8–11. https://ajindex.com/articles/129136

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Lindbald B, Stemby NH, Berquivist D. Incidence of VTE verified by necropsy over 30 years. BMJ 1992; 302: 709-711
  2. Sandler DA, Martin JF. Autopsy proven pulmonary embolism in hospital patient. J R Soc Med 1989; 82: 203-205
  3. Cohen AT, Edmondson RA, Phillips MJ,et al. The changing patterns of VTE disease. Heamostasis 1996; 26: 65-71
  4. Cohen AT, Tapson VF, Bergmann JF, et al. Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study. Lancet 2008; 371: 387- 394
  5. Geerts WH, Pineo GF, Heit JA, et al. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338-408
  6. Goldhaber SZ, Savage DD, Garrison RJ, et al. Risk factors for pulmonary embolism. The Framingham Study. Am J Med 1983; 74: 1923-1928
  7. Lindblad B, Eriksson A, Bergqvist D. Autopsy verified pulmonary embolism in surgical department: analysis of the period from 1951 to 1968. Br J Surg 1991; 78: 849-852
  8. Stein PD, Henry JW. Prevelance of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 1995; 108: 978-981
  9. Giuntini C, Di Ricco G, Marini C, Melillo E, Palla A. Pulmonary embolism: epidemiology. Chest 1995;107: 3S- 9S
  10. Horlander KT, Mannino DM, Leeper KV. Pulmonary embolism mortality in the United States, 1979-1998: an analysis using multiplecause mortality data. Arch Intern Med 2003; 20: 21-24
  11. Cushman M. Epidemiology and risk factors for venous thrombosis. Semin Hematol 2007; 44: 62-69
  12. Tsai AW, Cushman M, Rosamond WD, Heckbert SR, Polak JF, Folsom AR. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology. Arch Intern Med 2002; 162: 1182-1189
  13. Baglin TP, White K, Charles A. Fatal pulmonary embolism in hospitalized medical patients. J Clin Pathol 1997; 50: 609-610
  14. Heit JA, Silverstein MD, Mohr DN, et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 2001; 86: 452-463
  15. Prevention of fatal postoperative pulmonary embolism by low doses of heparin. An international multicentre trial. Lancet 1975; 2: 45-51
  16. Heit JA, Rooke TW, Silverstein MD, et all. Trends in the incidence of deep vein thrombosis and pulmonary embolism: A 25 year population – based study. J Vasc Surg 2001; 33: 1022-1027
  17. Stein PD, Firth JD. Deep venous thrombosis and pulmonary embolism. In Warrell DA, Cox TM, Fir